Login to Your Account



BIOTECH: A CROWD FAVORITE?

Venture capital holds steady but additional sources needed

By Peter Winter
Editor

Monday, January 13, 2014

It is that time of year again when the biotech lens sets its focus squarely on San Francisco with more than 12,000 business executives, investors and analysts heading to town for the J.P. Morgan Healthcare, Biotech Showcase and OneMedForum events. The common denominator for all these meetings is money.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription